PortfoliosLab logo
BKNG vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BKNG and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

BKNG vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Booking Holdings Inc. (BKNG) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

0.00%200.00%400.00%600.00%800.00%December2025FebruaryMarchAprilMay
835.89%
75.35%
BKNG
PFE

Key characteristics

Sharpe Ratio

BKNG:

1.76

PFE:

0.02

Sortino Ratio

BKNG:

2.32

PFE:

0.20

Omega Ratio

BKNG:

1.32

PFE:

1.02

Calmar Ratio

BKNG:

2.44

PFE:

0.01

Martin Ratio

BKNG:

6.64

PFE:

0.03

Ulcer Index

BKNG:

7.82%

PFE:

12.84%

Daily Std Dev

BKNG:

29.56%

PFE:

23.62%

Max Drawdown

BKNG:

-99.32%

PFE:

-58.96%

Current Drawdown

BKNG:

-1.64%

PFE:

-54.00%

Fundamentals

Market Cap

BKNG:

$160.24B

PFE:

$134.92B

EPS

BKNG:

$172.62

PFE:

$1.41

PE Ratio

BKNG:

28.44

PFE:

16.87

PEG Ratio

BKNG:

1.41

PFE:

0.57

PS Ratio

BKNG:

7.03

PFE:

2.22

PB Ratio

BKNG:

34.95

PFE:

1.53

Total Revenue (TTM)

BKNG:

$24.09B

PFE:

$62.46B

Gross Profit (TTM)

BKNG:

$23.57B

PFE:

$42.09B

EBITDA (TTM)

BKNG:

$7.56B

PFE:

$16.71B

Returns By Period

In the year-to-date period, BKNG achieves a 4.93% return, which is significantly higher than PFE's -7.27% return. Over the past 10 years, BKNG has outperformed PFE with an annualized return of 15.85%, while PFE has yielded a comparatively lower 1.22% annualized return.


BKNG

YTD

4.93%

1M

21.45%

6M

9.96%

1Y

46.65%

5Y*

30.57%

10Y*

15.85%

PFE

YTD

-7.27%

1M

5.35%

6M

-11.06%

1Y

-7.53%

5Y*

-3.74%

10Y*

1.22%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BKNG vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BKNG
The Risk-Adjusted Performance Rank of BKNG is 9191
Overall Rank
The Sharpe Ratio Rank of BKNG is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of BKNG is 8989
Sortino Ratio Rank
The Omega Ratio Rank of BKNG is 8989
Omega Ratio Rank
The Calmar Ratio Rank of BKNG is 9595
Calmar Ratio Rank
The Martin Ratio Rank of BKNG is 9090
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 4747
Overall Rank
The Sharpe Ratio Rank of PFE is 5050
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 4141
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 4141
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 5050
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BKNG vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Booking Holdings Inc. (BKNG) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for BKNG, currently valued at 1.76, compared to the broader market-2.00-1.000.001.002.003.00
BKNG: 1.76
PFE: 0.02
The chart of Sortino ratio for BKNG, currently valued at 2.32, compared to the broader market-6.00-4.00-2.000.002.004.00
BKNG: 2.32
PFE: 0.20
The chart of Omega ratio for BKNG, currently valued at 1.32, compared to the broader market0.501.001.502.00
BKNG: 1.32
PFE: 1.02
The chart of Calmar ratio for BKNG, currently valued at 2.44, compared to the broader market0.001.002.003.004.005.00
BKNG: 2.44
PFE: 0.01
The chart of Martin ratio for BKNG, currently valued at 6.64, compared to the broader market-10.000.0010.0020.00
BKNG: 6.64
PFE: 0.03

The current BKNG Sharpe Ratio is 1.76, which is higher than the PFE Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of BKNG and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
1.76
0.02
BKNG
PFE

Dividends

BKNG vs. PFE - Dividend Comparison

BKNG's dividend yield for the trailing twelve months is around 0.69%, less than PFE's 6.98% yield.


TTM20242023202220212020201920182017201620152014
BKNG
Booking Holdings Inc.
0.69%0.70%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.98%6.33%5.70%3.12%2.64%3.91%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

BKNG vs. PFE - Drawdown Comparison

The maximum BKNG drawdown since its inception was -99.32%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BKNG and PFE. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-1.64%
-54.00%
BKNG
PFE

Volatility

BKNG vs. PFE - Volatility Comparison

Booking Holdings Inc. (BKNG) has a higher volatility of 15.10% compared to Pfizer Inc. (PFE) at 10.91%. This indicates that BKNG's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%December2025FebruaryMarchAprilMay
15.10%
10.91%
BKNG
PFE

Financials

BKNG vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Booking Holdings Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20212022202320242025
4.76B
13.72B
(BKNG) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

BKNG vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Booking Holdings Inc. and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
96.1%
79.3%
(BKNG) Gross Margin
(PFE) Gross Margin
BKNG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Booking Holdings Inc. reported a gross profit of 4.58B and revenue of 4.76B. Therefore, the gross margin over that period was 96.1%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
BKNG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Booking Holdings Inc. reported an operating income of 1.06B and revenue of 4.76B, resulting in an operating margin of 22.3%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
BKNG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Booking Holdings Inc. reported a net income of 333.00M and revenue of 4.76B, resulting in a net margin of 7.0%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.